Tomoko Asano

472 total citations
27 papers, 352 citations indexed

About

Tomoko Asano is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Tomoko Asano has authored 27 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 10 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Tomoko Asano's work include Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (5 papers) and HER2/EGFR in Cancer Research (3 papers). Tomoko Asano is often cited by papers focused on Breast Cancer Treatment Studies (6 papers), Estrogen and related hormone effects (5 papers) and HER2/EGFR in Cancer Research (3 papers). Tomoko Asano collaborates with scholars based in Japan and United States. Tomoko Asano's co-authors include Tatsuya Toyama, Yumi Wanifuchi‐Endo, Satoru Takahashi, Nobuyasu Yoshimoto, Hiroko Yamashita, Yoshitaka Fujii, Shinya Sato, Masao Nawano, Hideyuki Sakoda and Motonobu Anai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Diabetes.

In The Last Decade

Tomoko Asano

26 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tomoko Asano Japan 10 174 123 71 61 49 27 352
Gang Sun China 12 139 0.8× 56 0.5× 73 1.0× 62 1.0× 32 0.7× 44 346
Mengdan Yan China 12 154 0.9× 87 0.7× 51 0.7× 29 0.5× 55 1.1× 43 346
Danthasinghe Waduge Badrajee Piyarathna United States 11 190 1.1× 114 0.9× 41 0.6× 59 1.0× 44 0.9× 14 324
Wei‐Chen Yen Taiwan 6 179 1.0× 91 0.7× 35 0.5× 59 1.0× 29 0.6× 8 308
Miriam McQuade United States 6 346 2.0× 193 1.6× 70 1.0× 30 0.5× 47 1.0× 14 513
Margherita Greco Italy 13 225 1.3× 64 0.5× 93 1.3× 45 0.7× 23 0.5× 22 423
Ana Alfaro Mexico 11 244 1.4× 93 0.8× 61 0.9× 66 1.1× 101 2.1× 33 528
Fahmida Rasha United States 10 119 0.7× 69 0.6× 85 1.2× 56 0.9× 30 0.6× 15 334
C. O'Callaghan United States 10 143 0.8× 59 0.5× 104 1.5× 55 0.9× 46 0.9× 14 360

Countries citing papers authored by Tomoko Asano

Since Specialization
Citations

This map shows the geographic impact of Tomoko Asano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoko Asano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoko Asano more than expected).

Fields of papers citing papers by Tomoko Asano

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoko Asano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoko Asano. The network helps show where Tomoko Asano may publish in the future.

Co-authorship network of co-authors of Tomoko Asano

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoko Asano. A scholar is included among the top collaborators of Tomoko Asano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoko Asano. Tomoko Asano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Matsumoto, Naoya, Yumi Wanifuchi‐Endo, Takashi Fujita, et al.. (2025). Prognosis, clinicopathological characteristics, and treatment patterns of patients with ER-intermediate-positive breast cancer undergoing long-term follow-up. ESMO Open. 10(4). 104508–104508.
2.
Terada, Mitsuo, Yumi Wanifuchi‐Endo, Takashi Fujita, et al.. (2024). Characterizing user demographics in posts related to breast, lung and colon cancer on Japanese twitter (X). Scientific Reports. 14(1). 6485–6485. 1 indexed citations
3.
Terada, Mitsuo, Kazuki Nozawa, Yumi Wanifuchi‐Endo, et al.. (2023). Fact-Checking Cancer Information on Social Media in Japan: Retrospective Study Using Twitter. JMIR Formative Research. 7. e49452–e49452. 10 indexed citations
4.
Katsuta, Eriko, Naoto Kondo, Yumi Wanifuchi‐Endo, et al.. (2022). Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer. PubMed Central. 2 indexed citations
5.
Kato, Akiko, Naoto Kondo, Yumi Wanifuchi‐Endo, et al.. (2022). Low TINAGL1 expression is a marker for poor prognosis in breast cancer. Journal of Cancer Research and Clinical Oncology. 149(8). 4771–4782. 5 indexed citations
6.
Terada, Mitsuo, Naoto Kondo, Yumi Wanifuchi‐Endo, et al.. (2022). Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study. Breast Cancer Research and Treatment. 195(3). 311–323. 5 indexed citations
7.
Kondo, Naoto, Yumi Wanifuchi‐Endo, Satoshi Osaga, et al.. (2022). Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer. Scientific Reports. 12(1). 16515–16515. 13 indexed citations
8.
Uchida, Megumi, Naoto Kondo, Yumi Wanifuchi‐Endo, et al.. (2021). Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery. Breast Cancer. 28(6). 1346–1357. 7 indexed citations
9.
Nishikawa, Sayaka, Tae‐Sun Kim, Naoto Kondo, et al.. (2021). Low RAI2 expression is a marker of poor prognosis in breast cancer. Breast Cancer Research and Treatment. 187(1). 81–93. 11 indexed citations
10.
Wanifuchi‐Endo, Yumi, Naoto Kondo, Takashi Fujita, et al.. (2021). Discovering novel mechanisms of taxane resistance in human breast cancer by whole‑exome sequencing. Oncology Letters. 23(2). 60–60. 1 indexed citations
11.
Kondo, Naoto, Yumi Wanifuchi‐Endo, Tomoko Asano, et al.. (2020). Abstract P6-04-11: LLGL2 is involved in resistance to tamoxifen in estrogen receptor-alpha positive breast cancer patients. Cancer Research. 80(4_Supplement). P6–4. 1 indexed citations
12.
Wanifuchi‐Endo, Yumi, Naoto Kondo, Nobuyasu Yoshimoto, et al.. (2015). HER2 mutation status in Japanese HER2-positive breast cancer patients. Breast Cancer. 23(6). 902–907. 8 indexed citations
13.
Kondo, Naoto, Nobuyasu Yoshimoto, Yumi Wanifuchi‐Endo, et al.. (2015). Prognostic impact of a single-nucleotide polymorphism near the CTSO gene in hormone receptor-positive breast cancer patients. International Journal of Clinical Oncology. 21(3). 539–547. 6 indexed citations
14.
Endo, Yui, Yuan Dong, Nobuyasu Yoshimoto, et al.. (2014). HER2 Mutation Status in Japanese HER2-negative Breast Cancer Patients. Japanese Journal of Clinical Oncology. 44(7). 619–623. 10 indexed citations
15.
Asano, Tomoko, Shinya Sato, Nobuyasu Yoshimoto, et al.. (2014). High Expression of LMTK3 is an Independent Factor Indicating a Poor Prognosis in Estrogen Receptor α-Positive Breast Cancer Patients. Japanese Journal of Clinical Oncology. 44(10). 889–897. 4 indexed citations
16.
Wanifuchi‐Endo, Yumi, Hiroko Yamashita, Satoru Takahashi, et al.. (2014). Immunohistochemical determination of the miR-1290 target arylamine N-acetyltransferase 1 (NAT1) as a prognostic biomarker in breast cancer. BMC Cancer. 14(1). 990–990. 47 indexed citations
17.
Toyama, Tatsuya, Satoru Takahashi, Shinya Sato, et al.. (2013). FOXA1 expression after neoadjuvant chemotherapy is a prognostic marker in estrogen receptor-positive breast cancer. Breast Cancer. 22(3). 308–316. 19 indexed citations
18.
Wanifuchi‐Endo, Yumi, Tatsuya Toyama, Satoru Takahashi, et al.. (2012). miR-1290 and its potential targets are associated with characteristics of estrogen receptor α-positive breast cancer. Endocrine Related Cancer. 20(1). 91–102. 57 indexed citations
19.
Anai, Motonobu, Makoto Funaki, Takehide Ogihara, et al.. (1999). Enhanced insulin-stimulated activation of phosphatidylinositol 3-kinase in the liver of high-fat-fed rats.. Diabetes. 48(1). 158–169. 90 indexed citations
20.
Takata, Kei‐ichi, Tomoko Asano, Y. Oka, & Hirofumi Hirano. (1992). IMMUNOCYTOCHEMICAL LOCALIZATION OF GLUT1, GLUT4, AND THEIR CHIMERIC GLUCOSE TRANSPORTER PROTEINS.(Physiology)Proceedings of the Sixty-Third Annual Meeting of the Zoologiacal Socistry of Japan. ZOOLOGICAL SCIENCE. 9(6). 1250. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gang Sun Breakdown of academic impact, for papers by Mengdan Yan Breakdown of academic impact, for papers by Danthasinghe Waduge Badrajee Piyarathna Breakdown of academic impact, for papers by Wei‐Chen Yen Breakdown of academic impact, for papers by Miriam McQuade Breakdown of academic impact, for papers by Margherita Greco Breakdown of academic impact, for papers by Ana Alfaro Breakdown of academic impact, for papers by Fahmida Rasha Breakdown of academic impact, for papers by C. O'Callaghan
Rankless by CCL
2026